the website you agree to our use of cookies . read more . accept en fi menu menu suomeksi my health asthma alzheimer s disease parkinson s disease breast cancer prostate cancer other websites wearingoff.eu orion group about orion products and services partnering and licensing investors media corporate governance sustainability contact us other websites fermion orion diagnostica careers at orion open vacancies working at orion students career stories research orion r & d research areas r & d pipeline scientific publications health professionals simdax.com dexdor.eu easyhaler.eu intensetimes.eu my health my health asthma alzheimer s disease parkinson s disease breast cancer prostate cancer orion group orion group about orion organisation orion history in brief management board of directors executive management board orion values mission and strategy partnering and licensing partnering opportunities alliance and partner management excellence products and services prescription drugs and self care products veterinary drugs active pharmaceutical ingredients diagnostic tests contract manufacturing investors orion as an investment business environment market reviews market reviews 2015 market reviews 2014 market reviews 2013 market reviews 2012 market reviews 2011 market reviews 2010 market reviews 2009 market reviews 2008 market reviews 2007 ceo s reviews ceo timo lappalainen s reviews 2015 ceo timo lappalainen s reviews 2014 ceo timo lappalainen s reviews 2013 ceo timo lappalainen s reviews 2012 ceo timo lappalainen s reviews 2011 ceo timo lappalainen s reviews 2010 ceo timo lappalainen s reviews 2009 ceo timo lappalainen s reviews 2008 ceo s reviews 2007 financial information key figures quarterly figures credit programmes outlook outlook for 2015 outlook for 2014 outlook for 2013 outlook for 2012 outlook for 2011 outlook for 2010 outlook for 2009 outlook for 2008 outlook for 2007 outlook for 2006 basis for outlook accounting policies calculation of key figures financial reviews and presentations other events capital markets days annual reports share information share capital and shares share related key figures treasury shares share price alternative exchanges monitor historical share prices total return calculator dividends analysts consensus estimates shareholders major shareholders by shares major shareholders by votes ownership structure flagging notifications insider register conversion of shares changes in shareholder s contacts transactions of managers messages to shareholders annual general meetings agm 2016 agm 2015 agm 2014 agm 2013 agm 2012 agm 2011 agm 2010 agm 2009 agm 2008 agm 2007 ir calendar silent period archive investor relations media stock exchange releases press releases managers transactions subscribe for press releases news material bank disclosure policy corporate governance corporate governance reports agm board of directors activities and duties principles concerning diversity of board of directors board members hannu syrj nen timo maasilta sirpa jalkanen eija ronkainen mikael silvennoinen heikki westerlund jukka ylpp board committees nomination committee matti kavetvuo kari jussi aho timo ritakallio seppo salonen charter of the nomination committee erkki etola authorisations of the board of directors ceo and executive management board activities and duties introductions of the executive management board members timo lappalainen satu ahom ki markku huhta koivisto olli huotari liisa hurme jari karlson virve laitinen reijo salonen employee representative marko torppala remuneration statement share based incentive plans risks and internal control strategic risks operational risks financial risks insider administration audit articles of association sustainability policies our approach to corporate responsibility code of conduct human resources policy ehs policy quality policy anti corruption policy supplier requirements pharmaceutical r & d ethics policy bioethics and animal welfare using human tissues gmo and stem cells ethics in the clinical research phases ethics in the marketing phase management approaches of responsibility management of product responsibility management of environmental responsibility labour practices and decent work management of economic responsibility human rights management management of society performance sustainability reports sustainability report 2015 management statement 2015 product responsibility environmental responsibility labour practices patient organisation collaboration stories about responsibility wearingoff.eu for parkinson s patients information about our self care products itsehoitoapteekki.fi orion helps plan to promote education recognitions and awards received by orion our practices in approving suppliers contact us invoicing addresses locations and contact persons sites and offices pharmaceutical manufacturing sales offices and representative offices animal health fermion contact persons research research orion r & d orion s r & d pipeline research areas r & d vocabulary the best r & d in the world drug development scientific publications careers at orion health professionals in support of girls rights we are continuing our cooperation with plan the aim is to improve the status and rights of girls in developing countries . according to a recent report the work is having a real impact on girls lives . read more orion group because i am a girl a campaign that became a movement this year plan is promoting girls rights by working to prevent very early motherhood and child marriages . orion is continuing to support this important work as corporate partner . read more orion group asthma medication spirometry corticosteroids what are they all about asthma is a chronic inflammatory disease of the lungs . this glossary explains asthma terms such as bronchodilator anti inflammatory medicine inhaler corticosteroid and spirometry . read more my health risk factors for prostate cancer symptoms and treatment of prostate cancer prostate cancer is the most widespread form of cancer that affects men and approximately 5 000 men are diagnosed with prostate cancer every year . this form of cancer usually develops slowly and does not necessarily produce any symptoms . forms of treatment are surgery or radiation therapy . read more parkinson s disease what does wearing off mean wearing off is a term that refers to a fluctuation in the symptoms of a person suffering from parkinson s disease . the patient s symptoms fluctuate depending on the effects of the medication and the symptoms of the disease . read more my health dogs are prone to fear noise noise anxiety is a common phobia among dogs . treatment should always be targeted as a dog s behavior may be caused by a variety of reasons . read more my health research areas orion develops new pharmaceuticals in three therapy areas . orion s pharmaceutical r & d focuses on the central nervous system cancer and critical care and inhalable easyhaler pulmonary drugs . orion also develops veterinary and generic drugs . read more research scientific publications here we provide for download scientific publications released at congresses in which orion is participating or in other contexts . read more orion research foundation s grants for 2017 are applicaple 1 august 14 september 2016 read more the best r & d in the world the orion r & d aims to be the best in the world . reijo salonen senior vice president of r & d tells why and how . read more drug development what does it take to develop a new medicine to start with you need a dedicated team of top scientists and other professionals . the journey might take up to fifteen years . take a look read more financial reviews and presentations orion will publish interim report for january september 2016 on tuesday 25 october 2016 approximately at 12 00 noon eest . the report and related presentation material will be available here promptly after publishing . read more stock exchange releases 10 11 2016 publishing of orion corporation s interim report for january september 2016 on 25 october 2016 10 5 2016 100 000 orion corporation a shares converted into b shares 9 7 2016 composition of the nomination committee of orion corporation 7 19 2016 orion group half yearly report january june 2016 the german center for neurodegenerative diseases and orion corporation start strategic collaboration open about orion orion is a globally operating finnish developer of pharmaceuticals and diagnostic tests a builder of well being . orion develops manufactures and markets human and veterinary pharmaceuticals active pharmaceutical ingredients and diagnostic tests . read more orion group agm 2016 the 2016 annual general meeting of orion was held on tuesday 22 march 2016 in messukeskus helsinki exhibition and convention centre . read more fermion invests in a new production facility in hanko reports the latest corporate governance statement of orion corporation is available at the archive of corporate governance statements . read more critical care one key area of orion s business is critical care . our portfolio includes simdax for acute heart failure and precedex and dexdor for sedation . read more about orion s proprietary products and other human pharmaceuticals . open working in the pharmaceutical industry orion is the largest employer in the finnish pharmaceutical industry . it is considered to be a good and reliable employer which is also indicated by its lower than average employee turnover . read more careers at orion applying for a job questions and answers how do i apply for a job at orion can i attach my cv to the application form how can i make sure my job application stands out from the rest these following tips will help you complete your job application . read more careers at orion for healthcare professionals are you a physician vet pharmacist or another healthcare professional health professionals site offers an easy access to our websites for professionals . read more health professionals smartphone app reminds you to take your medicine have you ever forgotten to take your medicine as directed the my well being app for smartphones reminds patients to take their medicine which supports the success of the treatment . read more my health change country suomeksi my health asthma alzheimer s disease parkinson s disease breast cancer prostate cancer other channels facebook twitter twitter ir youtube orion group about orion products and services partnering and licensing investors media sustainability corporate governance health professionals research orion r & d research areas r & d pipeline scientific publications careers at orion open vacancies working at orion students career stories other websites orion diagnostica fermion orion in other countries contact us feedback form about this website orion corporation orionintie 1a 02200 espoo po box 65 fi 02101 espoo finland . phone 358 10 4261 copyright orion corporation . company code vat 19992126 .